e-learning
resources
Berlin 2008
Tuesday, 07.10.2008
Issues in the management of COPD in the community
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Coronary artery disease risk score calculation and evaluation of statin and antithrombotic drug use among patients admitted with an acute exacarbation of COPD
C. Gwavava (Sheffield, United Kingdom)
Source:
Annual Congress 2008 - Issues in the management of COPD in the community
Session:
Issues in the management of COPD in the community
Session type:
Thematic Poster Session
Number:
3514
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Gwavava (Sheffield, United Kingdom). Coronary artery disease risk score calculation and evaluation of statin and antithrombotic drug use among patients admitted with an acute exacarbation of COPD. Eur Respir J 2008; 32: Suppl. 52, 3514
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Lane-hamilton syndrome and CCF: a fatal association
Panel discussion on acute decompensated pulmonary hypertension
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Current symptom-based risk scores for stable coronary artery disease evaluation are not applicable in COPD patients
Source: ERJ Open Res, 6 (4) 00492-2020; 10.1183/23120541.00492-2020
Year: 2020
Lipid profile in COPD patients with coronary artery disease comorbidity
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013
The risk of development of coronary artery disease and 10 years Systemic Coronary Risk Evaluation at patients with COPD
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010
Comparison of cardiopulmonary exercise test in COPD patients with and without coronary artery disease
Source: Annual Congress 2013 –The best posters in exercise testing and physical inactivity
Year: 2013
Impact of two 5-year anticoagulant strategies on survival and echocardiographic parameters in the patients with chronic thromboembolic pulmonary hypertension (CTEPH) who did not undergo pulmonary endarterectomy
Source: Annual Congress 2004 - Pulmonary embolism
Year: 2004
Risk assessment, therapy and cardiovascular comorbidity in patients with pulmonary arterial hypertension
Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Year: 2020
Prevalence of cardiovascular risk factors and coronary artery disease in patients with COPD
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010
Comorbit coronary artery disease is related to worse outcomes in patients hospitalised for COPD exacerbation
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016
Prevalence and underdiagnosis of COPD in patients with ischemic heart disease demonstrated by coronary angiography. Prognostic implications
Source: International Congress 2015 – COPD: notable points
Year: 2015
Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients
Source: Eur Respir J, 52 (5) 1800248; 10.1183/13993003.00248-2018
Year: 2018
Visual estimate of coronary artery calcium predicts cardiovascular disease in COPD
Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities
Year: 2016
Cardiointervalography in COPD patients with concomitant coronary heart disease
Source: Eur Respir J 2005; 26: Suppl. 49, 509s
Year: 2005
Role of a clinical prediction score in a chronic thromboembolic pulmonary hypertension rule-out strategy
Source: Eur Respir J, 51 (4) 1702576; 10.1183/13993003.02576-2017
Year: 2018
Predictors of coronary heart disease in patients with COPD
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Pulmonary angioplasty vs exclusive medical treatment in inoperable chronic thromboembolic hypertension–initial outcomes from a pulmonary hypertension centre
Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension
Year: 2020
The beta-blockers in combined treatment of coronary heart disease in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD treatment
Year: 2013
Beta-blocker use and risk of acute exacerbations of COPD following first-time myocardial infarction. A Danish nationwide cohort study.
Source: International Congress 2019 – More and more COPD
Year: 2019
Outcome of pulmonary endarterectomy in symptomatic chronic thromboembolic disease
Source: Eur Respir J 2014; 44: 1635-1645
Year: 2014
Supervised exercise training in patients with chronic thromboembolic pulmonary hypertension (CTEPH) as early follow-up treatment after pulmonary endarterectomy (PEA) – a prospective cohort study
Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension
Year: 2020
Coronary artery calcification in COPD is associated with adverse functional assessments and mortality
Source: Annual Congress 2012 - COPD is not a pulmonary disease alone
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept